ENCELTO
STN: BLA 125798
Proper Name: revakinagene taroretcel-lwey
Tradename: ENCELTO
Manufacturer: Neurotech Pharmaceuticals, Inc.
Indication:
- For The treatment of adults with idiopathic macular telangiectasia type 2 (MacTel)
On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.